CSM™ BRIDGES CONTINENTS WITH NEW CLINICAL SUPPLIES PARTNER
Clinical Supplies Management Inc. (CSM) in Fargo, North Dakota has established a cross-continent relationship with leading UK outsource services provider Brecon Pharmaceuticals Ltd.
FARGO – ND – Clinical Supplies Management Inc. (CSM) in Fargo, North Dakota has established a cross-continent relationship with leading UK outsource services provider Brecon Pharmaceuticals Ltd.
This new relationship provides CSM with a "local" supplier for storage and distribution facilities in Europe, as well as access to Brecon's analytical services and extensive QP release expertise when required. The reciprocal nature of the agreement means that Brecon Pharmaceuticals will use CSM as their US-based clinical supplies partner.
Commenting on the new relationship, CSM's President, Gerald Finken, said, "This new agreement with Brecon enhances our European capabilities for multi-national trials. It is important to have local European storage and distribution solutions for our customers and Brecon provides the high standards we require."
Brecon's Director of Clinical Trials Services, Sue Miles, said, "CSM's attention to customer service complements Brecon's own commitment to excellence and I am confident that this partnership will extend Brecon's global reach".
About CSM
CSM is a clinical trial support services company committed to advancing clinical trials for pharmaceutical and biotechnology companies by providing innovative and customized services in the areas of clinical supplies and subject retention and compliance. CSM is the innovator of On-Demand packaging and labeling, which has greatly improved efficiencies in the clinical supplies process and saved time and money for numerous clients.
About Brecon
Brecon Pharmaceuticals provides packaging, storage, and distribution services for clinical trial materials throughout the world. Brecon's team of QPs and on-site analytical laboratory also ensure efficient and timely import and release of clinical trial supplies into the EU.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
